Alnylam to webcast conference call discussing second quarter 2025 financial results

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that it will report financial results for the second quarter ending june 30, 2025 on thursday, july 31, 2025, before the u.s. financial markets open. management will provide an update on the company and discuss second quarter 2025 results as well as expectations for the future via conference call on thursday, july 31, 2025 at 8:30 am et. a live audio webcast of.
ALNY Ratings Summary
ALNY Quant Ranking